Relapsed Acute Myeloid Leukemia With Isolated Conjugated Hyperbilirubinemia Secondary to High-Dose Cytarabine Therapy

被引：0
|
作者：
Akpara, Ugochukwu [1 ]
Choi, Anthony J. [2 ]
Wan, David [3 ]
机构：
[1] New York Presbyterian Weill Cornell Med Ctr, Brooklyn, NY USA
[2] New York Presbyterian Weill Cornell Med Ctr, New York, NY USA
[3] Cornell Univ, Weill Cornell Med Coll, New York, NY 10021 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2020年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S2562
引用
收藏
页码：S1348 / S1348
页数：1
相关论文
共 50 条
  • [31] High-dose cytarabine in consolidation therapy for acute promyelocytic leukemia (APL).
    Schlenk, RF
    Fröhling, S
    del Valle, F
    Dreger, P
    Fischer, JT
    Glasmacher, A
    Götze, K
    Grimminger, W
    Haas, R
    Hahn, U
    Hartmann, F
    Koller, E
    Megentahler, HG
    Schmid, P
    Waterhouse, C
    Weber, C
    Weber, W
    Döhner, K
    Döhner, H
    BLOOD, 2000, 96 (11) : 723A - 723A
  • [32] Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study
    van Eijkelenburg, Natasha K. A.
    Rasche, Mareike
    Ghazaly, Essam
    Dworzak, Michael N.
    Klingebiel, Thomas
    Rossig, Claudia
    Leverger, Guy
    Stary, Jan
    De Bont, Eveline S. J. M.
    Chitu, Dana A.
    Bertrand, Yves
    Brethon, Benoit
    Strahm, Brigitte
    van der Sluis, Inge M.
    Kaspers, Gertjan J. L.
    Reinhardt, Dirk
    Zwaan, C. Michel
    HAEMATOLOGICA, 2018, 103 (09) : 1484 - 1492
  • [33] The association of topotecan and cytarabine in the treatment of secondary or relapsed acute myeloid leukemia
    Pagano, L
    Mele, L
    Voso, MT
    Chiusolo, P
    Putzulu, R
    Mazzotta, S
    Leone, G
    HAEMATOLOGICA, 2001, 86 (04) : 440 - 441
  • [34] High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia
    Schlenk, RF
    Germing, U
    Hartmann, F
    Glasmacher, A
    Fischer, JT
    Fuentes, FDY
    Götze, K
    Pralle, H
    Nerl, C
    Salwender, H
    Grimminger, W
    Petzer, A
    Hensel, M
    Benner, A
    Zick, L
    Döhner, K
    Fröhling, S
    Döhner, H
    LEUKEMIA, 2005, 19 (06) : 978 - 983
  • [35] High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia
    R F Schlenk
    U Germing
    F Hartmann
    A Glasmacher
    J T Fischer
    F del Valle y Fuentes
    K Götze
    H Pralle
    C Nerl
    H Salwender
    W Grimminger
    A Petzer
    M Hensel
    A Benner
    L Zick
    K Döhner
    S Fröhling
    H Döhner
    Leukemia, 2005, 19 : 978 - 983
  • [36] IDARUBICIN AND HIGH-DOSE CYTARABINE IN THE TREATMENT OF REFRACTORY AND RELAPSED ACUTE LYMPHOBLASTIC-LEUKEMIA
    GIONA, F
    TESTI, AM
    AMADORI, S
    MELONI, G
    CAROTENUTO, M
    RESEGOTTI, L
    COLELLA, R
    LEONI, P
    CARELLA, AM
    GROTTO, P
    MINIERO, R
    MANDELLI, F
    ANNALS OF ONCOLOGY, 1990, 1 (01) : 51 - 55
  • [37] Idarubicin, high-dose cytarabine and etoposide for remission induction in patients with relapsed acute leukemia
    Mehta, J
    Powles, R
    Singhal, S
    Horton, C
    Prediville, J
    Glynne, P
    Zomas, A
    Hamblin, S
    Saso, R
    Mackay, H
    Treleaven, J
    BLOOD, 1995, 86 (10) : 2041 - 2041
  • [38] AMSACRINE WITH HIGH-DOSE CYTARABINE IS HIGHLY EFFECTIVE THERAPY FOR REFRACTORY AND RELAPSED ACUTE LYMPHOBLASTIC-LEUKEMIA IN ADULTS
    ARLIN, ZA
    FELDMAN, E
    KEMPIN, S
    AHMED, T
    MITTELMAN, A
    SAVONA, S
    ASCENSAO, J
    BASKIND, P
    SULLIVAN, P
    FUHR, HG
    MERTELSMANN, R
    BLOOD, 1988, 72 (02) : 433 - 435
  • [39] High-Dose Cytarabine Alone Versus Cytarabine Plus Anthracycline for Consolidation Therapy in Non-Promyelocytic Acute Myeloid Leukemia
    Kim, Sung-Hyun
    Kim, So Yeon
    Lee, Ji Hyun
    Lee, Suee
    Oh, Sung Yong
    Kim, Hyo-Jin
    Kim, Dae Sik
    Kang, Ka-Won
    Lee, Se Ryeon
    Park, Yong
    Sung, Hwa Jung
    Choi, Chul Won
    Kim, Byung Soo
    BLOOD, 2015, 126 (23)
  • [40] Safety and feasibility of outpatient high-dose cytarabine (HIDAC) and intermediate-dose cytarabine (IDAC) for consolidation therapy in acute myeloid leukemia (AML).
    Li, Wenhui
    Simondsen, Katherine
    Lee, Jamie
    Elharake, Maher
    Kubal, Timothy Edward
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345